Suchergebnisse - "Dong, Tianhui"

PubPharm (21)

1

STAT5 is essential for inducing the suppressive subset and attenuate cytotoxicity of Vδ2+ T cells in acute myeloid leukemia

enthalten in: Cancer letters | 2024

von Cheng, C. | Liang, S. | Yue, K. | +8

2

Exploring the Predictors of the Discrepancy Between Quantitative Flow Ratio and Fractional Flow Reserve Measurements

enthalten in: Anatolian journal of cardiology | 2023

von Dong, T. | Zhou, L. | Gong, X. | +3

3

Characteristics of Wellens' Syndrome in the Current PCI Era : A Single-Center Retrospective Study

enthalten in: Emergency medicine international | 2023

von Zhou, L. | Gong, X. | Chen, H. | +3

4

Distinct activities of Vδ1+ T-cells upon different cytomegalovirus reactivation status after haematopoietic transplantation

enthalten in: Immunology | 2022

von Liu, R. | Wu, N. | Gao, H. | +9

5

CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vδ2+ T cell cytotoxicity

enthalten in: Annals of hematology | 2022

von Dong, T. | Wu, N. | Gao, H. | +5

6

CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards $ Vδ2^{+} $ T cell cytotoxicity

enthalten in: Annals of hematology | 2022

von Dong, T. | Wu, N. | Gao, H. | +5

7

CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards $ Vδ2^{+} $ T cell cytotoxicity

enthalten in: Annals of hematology | 2022

von Dong, T. | Wu, N. | Gao, H. | +5

8

CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards $ Vδ2^{+} $ T cell cytotoxicity

enthalten in: Annals of hematology | 2022

von Dong, T. | Wu, N. | Gao, H. | +5

9

Wellens’ Syndrome: Incidence, Characteristics, and Long-Term Clinical Outcomes

enthalten in: ResearchSquare.com | 2022

von Zhou, L. | Gong, X. | Dong, T. | +3

10

Wellens' syndrome : incidence, characteristics, and long-term clinical outcomes

enthalten in: BMC cardiovascular disorders | 2022

von Zhou, L. | Gong, X. | Dong, T. | +3